Home
>
US Stocks
>
United Therapeutics Corp
United Therapeutics Corp
UTHR

United Therapeutics Corp

$184.5210.32%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
183.08
Today Low/High
180.25 / 184.98
52 Week Low/High
$98.37 / $216.9
P/E ratio
19.42
Market Cap
$9.15B

Company Details

United Therapeutics Corporation focuses on the strength of a balanced, value-creating biotechnology model. We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture and our bioinformatics leadership. We also believe that our determination to be responsible citizens - having a positive impact on patients, the environment and society - will sustain our success in the long term. Through our wholly-owned subsidiary, Lung Biotechnology PBC, we are focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.
Organisation
United Therapeutics Corp
Headquaters
Silver Spring, Maryland, United States
Employees
950
Industry
Health Technology
CEO
Martine Rothblatt

Discover more

Frequently Asked Questions

What is United Therapeutics Corp share price today

Can Indians buy United Therapeutics Corp shares?

How can I buy United Therapeutics Corp shares from India?

Can Fractional shares of United Therapeutics Corp be purchased?

What are the documents required to start investing in United Therapeutics Corp stocks?

We are a SEBI registered investement advisor